Production (Stage)
iSpecimen Inc.
ISPC
$1.14
$0.021.79%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -53.82% | -42.70% | -4.17% | 76.22% | -22.38% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -53.82% | -42.70% | -4.17% | 76.22% | -22.38% |
| Cost of Revenue | -34.27% | -7.22% | 11.61% | 66.87% | -12.81% |
| Gross Profit | -68.98% | -86.81% | -20.03% | 86.56% | -28.46% |
| SG&A Expenses | -55.80% | 65.19% | -22.55% | -22.38% | -3.78% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -49.04% | 34.33% | -12.16% | -2.73% | -3.68% |
| Operating Income | 45.40% | -103.43% | 22.27% | 38.75% | -18.02% |
| Income Before Tax | 42.86% | -96.77% | 31.79% | 39.46% | -19.34% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 42.86% | -96.77% | 31.79% | 39.46% | -19.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 42.86% | -96.77% | 31.79% | 39.46% | -19.34% |
| EBIT | 45.40% | -103.43% | 22.27% | 38.75% | -18.02% |
| EBITDA | 46.42% | -105.57% | 24.18% | 39.92% | -17.29% |
| EPS Basic | 88.77% | 21.07% | 55.01% | 51.77% | -17.36% |
| Normalized Basic EPS | 88.77% | 21.07% | 55.01% | 51.77% | -17.36% |
| EPS Diluted | 88.77% | 21.07% | 55.01% | 51.77% | -17.36% |
| Normalized Diluted EPS | 88.77% | 21.07% | 55.01% | 51.77% | -17.36% |
| Average Basic Shares Outstanding | 408.78% | 149.29% | 51.58% | 25.53% | 1.69% |
| Average Diluted Shares Outstanding | 408.78% | 149.29% | 51.58% | 25.53% | 1.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |